This groundbreaking research unveils that advanced artificial intelligence successfully developed Redwood, a high-performance ...

AI’s Next Breakthrough Could Be Biomedical Discovery / AI in healthcare, AI-innovation, artificial intelligence, Biomedical ...

How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

Recursion Pharmaceuticals (RXRX) came out with a quarterly loss of $0.25 per share versus the Zacks Consensus Estimate of a loss of $0.23. This compares to a loss of $0.41 per share a year ago. These ...

Follow this section to personalize your feed and get instant alerts. WHY FOLLOW? Update your preferences in Account Settings Personalized Content Follow this tag to personalize your feed and get ...

A new study published in Nature Reviews Biodiversity by an international team of experts led by researchers from the ...

Do your social media accounts feed you content that reflects your core beliefs and guiding principles? Our new research published in the Proceedings of the National Academy of Sciences shows that the ...

Machine learning is the ability of a machine to improve its performance based on previous results. Machine learning methods enable computers to learn without being explicitly programmed and have ...

White House Office of Science and Technology policy director Michael Kratsios discusses the Trump administration's push for fewer regulations on artificial intelligence at the G20 on 'Kudlow.' The new ...

This price reflects trading activity during the overnight session on the Blue Ocean ATS, available 8 PM to 4 AM ET, Sunday through Thursday, when regular markets are closed. The above button links to ...

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...